The deal gives Mylan a wide array of
Abbott brands in developed markets outside the
United States that have annual sales of almost $2 billion, including pain drug Brufen and
influenza vaccine In...
Regardless of whether the deal arises from friendly negotiations or a
hostile approach, it is likely to end on good terms if successfully
completed, Pfizer Chief Executive Ian Read said.
The two drugmakers have resumed talks about a trans-Atlantic merger after Pfizer sweetened the terms of an earlier takeover offer for its British rival.
HOT STOCKS
NSE
BSE
Stay informed about the best performers in Nifty 50. Stocks whose intraday price rose from their previous close are called gainers